Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results tomorrow after market hours. Here’s what to expect.
Chemed missed analysts’ revenue expectations by 1% last quarter, reporting revenues of $606.2 million, up 7.4% year on year. It was a softer quarter for the company, with a miss of analysts’ full-year EPS guidance estimates.
Is Chemed a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Chemed’s revenue to grow 8.6% year on year to $636.1 million, improving from the 7.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $6.78 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings.
Looking at Chemed’s peers in the senior health, home health & hospice segment, some have already reported their Q4 results, giving us a hint as to what we can expect. AdaptHealth posted flat year-on-year revenue, beating analysts’ expectations by 3.3%, and Addus HomeCare reported revenues up 7.5%, topping estimates by 2.7%.
Read our full analysis of AdaptHealth’s results here and Addus HomeCare’s results here.
Stocks generally had a good 2024. The Fed fought high inflation and won without sending the economy into a recession, otherwise lovingly known as a soft landing. The US Central Bank is now cutting rates. That, plus the election of Donald Trump in November 2024, sent markets even higher, and while some of the senior health, home health & hospice stocks have shown solid performance, the group has generally underperformed, with share prices down 5.4% on average over the last month. Chemed is down 4.8% during the same time and is heading into earnings with an average analyst price target of $663.67 (compared to the current share price of $546.01).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
